← back to search

Matthew S. Durstenfeld

University of California System · US
Area of research
Neurology · Infectious Diseases
Research interest
Research interests include Long-Term Effects of COVID-19, COVID-19 Clinical Research Studies, HIV-related health complications and treatments, and Heart Failure Treatment and Management.
h-index
26
citations
3,210
works
122
NIH funding
primary concept
Medicine
email

Recent publications

Multicenter study of heart failure phenotypes and physician-adjudicated causes in people with HIV
AIDS 2025cited by 2position: middledoi
Abstract 4364733: Acceptability of Cardiovascular Prevention Strategies Among People With HIV: a Mixed-Methods Study
Circulation 2025cited by 0position: firstdoi
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Science Translational Medicine 2024cited by 89position: middledoi
Plasma-based antigen persistence in the post-acute phase of COVID-19
The Lancet Infectious Diseases 2024cited by 66position: middledoi
Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study
Journal of Medical Virology 2024cited by 53position: firstdoi
Stakeholder Perspectives on a Heart Failure With Reduced Ejection Fraction Polypill: A Multi-Center Mixed Methods Study
Circulation Cardiovascular Quality and Outcomes 2024cited by 4position: middledoi
Factors Associated With Long COVID Symptoms in an Online Cohort Study
Open Forum Infectious Diseases 2023cited by 94position: firstdoi
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
PLoS ONE 2023cited by 56position: middledoi
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients
JCI Insight 2023cited by 53position: middledoi
Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019
The Journal of Infectious Diseases 2023cited by 34position: firstdoi
Chronic viral coinfections differentially affect the likelihood of developing long COVID
Journal of Clinical Investigation 2022cited by 218position: middledoi
Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults
JAMA Network Open 2022cited by 180position: firstdoi
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
Neurology Neuroimmunology & Neuroinflammation 2022cited by 84position: middledoi
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection
AIDS 2022cited by 62position: middledoi
Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies
Pathogens and Immunity 2022cited by 57position: middledoi
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
JCI Insight 2022cited by 42position: firstdoi
Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post–Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID
The Journal of Infectious Diseases 2022cited by 31position: middledoi
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
The Journal of Infectious Diseases 2021cited by 327position: middledoi
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement
Open Forum Infectious Diseases 2021cited by 99position: middledoi
Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System
JACC Heart Failure 2016cited by 93position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Priscilla Y. Hsue · University of California, Los Angeles12 papers (2021–2025)Michael J. Peluso · Cardiff University11 papers (2021–2024)Steven G. Deeks · University of California, San Francisco10 papers (2021–2024)Timothy J. Henrich · World Wide Web Consortium9 papers (2021–2024)Jeffrey N. Martin · Global Solutions for Infectious Diseases8 papers (2021–2024)J. Daniel Kelly · San Francisco VA Medical Center8 papers (2021–2024)Rebecca Hoh · World Wide Web Consortium7 papers (2021–2024)Scott Lu · Centre for Global Health Research6 papers (2021–2024)Sarah A. Goldberg · Centre for Global Health Research5 papers (2021–2024)David V. Glidden · San Francisco General Hospital4 papers (2021–2024)John Winslow · LabCorp (United States)4 papers (2021–2023)Ahmed Chenna · LabCorp (United States)4 papers (2021–2023)Christos J. Petropoulos · LabCorp (United States)4 papers (2021–2023)Viva Tai · University of California, San Francisco4 papers (2021–2022)Brandon C. Yee · LabCorp (United States)4 papers (2021–2023)Alexis L. Beatty · National Confidential Enquiry into Patient Outcome and Death3 papers (2022–2024)Bryan Greenhouse · U.S. President's Malaria Initiative3 papers (2021–2023)Khamal Anglin · San Francisco General Hospital3 papers (2022–2024)Mark J. Pletcher · Department of Epidemiology and Biostatistics2 papers (2023–2024)Noah D. Peyser · University of California, San Francisco2 papers (2023–2024)